About 2 results found for searched term "AP24534" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1648 | AP24534 | Src-bcr-Abl |
| Ponatinib | ||
| Ponatinib (AP24534) is a novel potent, orally available small molecule multitargeted kinase inhibitor of BCR-ABL, PDGFRα, c-Src, c-Kit, FGFR and VEGFR. | ||
| M9009 | Ponatinib hydrochloride | Src-bcr-Abl |
| AP24534 HCl | ||
| Ponatinib hydrochloride is a potent, orally available multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
